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INTRODUCTION 
Positional plagiocephaly is a condition of asymmetrical cranial 
morphology caused by an extrinsic factor, such as pressure, rather 
Effectiveness of Helmet Cranial Remodeling              
in Older Infants with Positional Plagiocephaly
Background: Management of positional plagiocephaly by wearing a cranial molding 
helmet has become a matter of growing medical interest. Some research studies re-
ported that starting helmet therapy early (age 5 to 6 months) is important and leads to 
a significantly better outcome in a shorter treatment time. The aim of the present study 
was to evaluate the effectiveness of cranial remodeling treatment with wearing helmet 
for older infants (≥18 months). 
Methods: We conducted a retrospective study of 27 infants with positional plagioceph-
aly without synostosis, who were started from 2008 to 2012. Every child underwent a 
computerized tomography (CT) before starting helmet therapy to exclude synostosis 
of the cranial sutures and had CT performed once again after satisfactory completion 
of therapy. Anthropometric measurements were taken on using spreading calipers in 
every child. The treatment effect was compared using cranial vault asymmetry (CVA) 
and the cranial vault asymmetry index (CVAI), which were obtained from diagonal 
measurements before and after therapy.
Results: The discrepancy of CVA and CVAI of all the patients significantly decreased 
after cranial molding helmet treatment in older infants (≥18 months) 7.6 mm from 15.6 
mm to 8 mm and 4.51% from 9.42% to 4.91%. Six patients had confirmed successful 
outcome, and all subjects were good compliance patients. The treatment lasted an 
average of 16.4 months, was well tolerated, and had no complication. Additionally, the 
rate of the successful treatment (final CVA ≤5 mm) significantly decreased when the 
wearing time per was shorter.
Conclusion: This study showed that treatment by cranial remodeling orthosis was 
effective if the patient could wear the helmet longer and treatment duration was some-
what longer than in younger patients, well tolerated in older infants and had no morbid-
ity. This therapeutic option is available and indicated in these older infants before other 
cranial remodeling surgery.
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than an intrinsic factor [1]. It is also called non-synostotic plagio-
cephaly or deformational plagiocephaly. There are many causes of 
positional plagiocephaly, but sleeping position is assumed to play 
a major role in etiology. The incidence of positional plagiocephaly 
has increased with the start of ‘Back to Sleep’ campaign by the 
American Academy of Pediatrics [2-6] and ranges from 1 in 300 
live births to 22.1 percent [7,8]. 
Increasing quality of life and awareness of problems caused by 
positional plagiocephaly have raised parental demand for correc-
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tion of this condition. In recent years, the number of parents seek-
ing counsel for positional plagiocephaly has increased at our clinic.
Many studies that have reported that positional plagiocephaly 
does not improve naturally [9]. Asymmetry of face and position of 
ear can remain permanent [1]. Helmet orthoses can restore a de-
gree of symmetry to the cranium by limiting growth in protruded 
areas and by allowing rapid growth in areas which are flat [10].
Until now, studies have indicated that early initiation of helmet 
therapy is important and leads to a significantly better outcome 
within a shorter treatment time. However, few studies have reported 
helmet therapy in older patients. The purpose of this study was to 
determine whether helmet therapy was eﬀective in older children 
and to further identify factors associated with desired outcomes.
METHODS
A retrospective study was conducted for and identiﬁed 27 infants 
with positional plagiocephaly between 2008 and 2012. The inclu-
sion criteria of this study were 1) diagnosis of non-synostotic pla-
giocephaly without surgical treatment, 2) over 18 months of age 
when cranial remodeling helmet was begun, and 3) completion of 
helmet therapy or regular follow-up for at least one year with 
complete documentation. 
Every child included in the study underwent a computerized 
tomography (CT) before starting helmet therapy to exclude 
synostoses of the cranial sutures. A repeat CT scan was performed 
after completion of therapy (Fig. 1).
Anthropometric measurements were made using calipers, as 
well as using CT images. Eﬀectiveness of treatment was compared 
using cranial vault asymmetry (CVA) and the cranial vault asym-
metry index (CVAI), which were obtained from measurements 
taken before and after therapy (Fig. 2).
The most prominent frontozygomatic area-to-contralateral oc-
cipital distance was measured on both sides in every patient, using 
a spreading caliper. The fzA is the most prominent frontozygomat-
ic area and euA is the oppose side from fzA. Thus the longest dis-
tance in the vertex view is form fzA to euA. The fzB means the most 
depressed frontozygomatic area and euB is other side from fzB. The 
distances were defined as diagonal A (the distance from fzA to 
euA) or B (the distance from fzB to euB) (A>B), and the cranial vault 
asymmetry (CVA) (diagonal A–diagonal B) and cranial vault 
asymmetry index (CVAI) ([diagonal A–diagonal B]/[diagonal A×
100]) [10] were measured. CVA and CVAI were compared from 
the initial measurement to measurements made at each visit to as-
sess the treatment progress (Fig. 1). A ﬁnal CVA less than 5 mm 
was considered as an indicator of successful treatment. 
We also analyzed patient compliance. Good compliance meant 
helmet application for greater than 17 hours per a day. All patients 
with successful outcomes wore the helmet for greater than 17 hours.
Patients were divided into successful and unsuccessful out-
Fig. 1. Appearance and computed tomography of a positional plagiocephaly patient.
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come groups, and were compared using a paired sample T-test 
and one way analysis of variance test. Diﬀerences were considered 
statistically significant for p<0.05. Data analysis was performed 
using SPSSWIN ver. 21.0. (IBM Co., Armonk, NY, USA).
RESULTS 
Of the 27 patients, the mean age was 29.7 months (range, 18 to 75 
months) at initiation of helmet therapy. The initial mean CVA and 
CVAI were 15.6 mm (range, 6 to 26 mm) and 9.42% (range, 3.53% 
to 16.08%), respectively. The mean helmet application time was 
17.5 hours per a day (range, 10 to 22.3 hours), and the mean dura-
tion of overall treatment was 16.4 months (range, 7 to 33.6 
months) (Table 1).
At the end of follow up period, the mean CVA and CVAI were 
8 mm (range, 1 to 15 mm) and 4.91% (range, 0.59 % to 9.68 %). This 
was approximately a 50% improvement compared to the initial 
CVA and CVAI, respectively (p<0.001).
Six of 27 patients (22%) were considered to have successful out-
comes. For this group of 6 patients, the mean age at helmet thera-
py initiation was 27.2 months, with initial CVA of 12.5 mm versus 
final CVA of 2.5 mm. The mean compliance was 21.2 hour/day 
(Table 2). Interestingly, the mean helmet therapy duration was 
shorter for patients with successful outcomes than those without 
(10.8 months vs. 18.4 months). Initial CVA, CVAI, or age at initia-
tion of therapy were not associated with successful outcomes. 
Fig. 2. Diagonal measurement of patient and the treatment effect of the helmet therapy strategy.
Table 1. The patient’s initial value, compliance and helmet therapy 
duration 
Variable Value Range
Initial CVA (mm) 15.6 6–26
Initial CVAI (%) 9.42 3.53–16.05
Compliance (hr/day) 17.5 10–22.3
Helmet therapy duration (mo) 16.4 7–33.6
CVA, cranial vault asymmetry; CAVI, cranial vault asymmetry index.
Table 2. The result of successful outcome patient
No.
Age of start 
helmet therapy (mo)
Initial CVA 
(mm)
Final CVA 
(mm)
Initial CVAI 
(%)
Final CVAI 
(%)
Treatment period 
(mo)
Compliance 
(hr/day)
1 31.3 9.0 1.0 5.36 0.61 12.2 21.3
2 17.1 12.0 1.0 7.14 0.59 7.8 19.2
3 26.9 22.0 13.0 4.07 1.18 5.9 19.6
4 33.7 7.0 2.0 2.94 1.78 13.4 20.0 
5 28.8 19.0 4.0 11.18 2.48 19.4 21.0
6 25.6 6.0 4.0 3.53 2.38 12.2 20.3
Mean 27.2 12.5 2.5 6.56 1.51 10.84 20.2
CVA, cranial vault asymmetry; CAVI, cranial vault asymmetry index.
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However, final CVA, final CVAI, treatment duration, and daily 
helmet wear were signiﬁcantly diﬀerent (Table 3). 
Those who were confirmed as poor compliance among pa-
tients with failed treatment (n=6) had improved CVA by 5 mm 
only (from 16 to 11 mm) and CVAI was 2.96% (from 9.23% to 
6.27%), even though their mean treatment period was compara-
tively long at 20.6 months. Patients with good compliance but 
with treatment failure (n=12) had improved CVA and CVAI from 
17 to 10 mm and 10.63% to 5.28%, respectively. Despite not being 
determined as a successful outcome, their results were consider-
ably better (Table 3).
There were no complications during the follow-up period.
Case
A male toddler was begun on helmet treatment at 23 months of 
age. The child wore the helmet for an average of 22.3 hours a day 
with an overall treatment duration of 6.3 months (Fig. 3). His ini-
tial CVA and ﬁnal CVA were 19 mm and 4 mm, respectively. Ini-
tial CVAI was 11.18 %, and ﬁnal CVAI was 2.48%. 
DISCUSSION 
In the past two decades, parents have shown increasing interest in 
positional plagiocephaly. Awareness regarding plagiocephaly and 
the resultant asymmetry of face and unforeseen functional prob-
Table 3. The result of patient data about compliance
Variable 
Success Fail
p-value
Good compliance (n=6) Good compliance (n=12) Poor compliance (n=9) Mean   
Age of start helmet therapy (mo) 27.2 31.9 28.3 30.3 0.232
Initial CVA (mm) 12.5 17 16 17 0.216
Final CVA (mm) 2.5 10 11 9 0.000
Initial CVAI (%) 6.56 10.63 9.23 10.03 0.168
Final CVAI (%) 1.51 5.28 6.27 5.71 0.000
Treatment period (mo) 10.84 17.53 18.31 18.42 0.001
Compliance (hr/day) 21.2 18.9 14.9 17.1 0.000
CVA, cranial vault asymmetry; CAVI, cranial vault asymmetry index.
Fig. 3. Case. (A) Three dimensional (3D) computed tomography (CT) scan before helmet therapy, CVA=19 mm, CVAI=11.18%. (B) 3D CT scan 
after 6.3 months helmet therapy, CVA=4 mm, CVAI=2.48%. CVA, cranial vault asymmetry; CAVI, cranial vault asymmetry index.  
A B
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lems has led to a rising demand for treatment [11]. A number of 
articles have addressed this issue. There are several possible treat-
ment options, such as physiotherapy, head repositioning, and hel-
met therapy [12,13]. Most studies have reported that treatment 
such as physiotherapy and head repositioning fail after first 6 
month of life [13]. 
While the timing of helmet therapy is considered important, 
also, the debate continues regarding the optimal timing of helmet 
therapy as the most important factor influencing the outcome. 
The current consensus is that helmet treatment is best if initiated 
within the ﬁrst 12 months of life, since 85% of cranial growth oc-
curs during this time. However, helmet orthoses are considered 
eﬀective up to 18 months of age. Grigsby [14] compared diﬀerenc-
es in treatment duration and outcome of cranial molding therapy 
between children younger and older than 12 months and 12 
months. The authors found that cranial molding treatment was 
eﬀective in the older group, but required twice the treatment du-
ration for similar amount of correction.
It is no uncommon that parents visit our out-patient clinic with 
children who are older than 18 months with signiﬁcant positional 
plagiocephaly. In the past, we recommend against helmet therapy, 
considering the lack of evidence in these older children and the 
high cost of these custom helmets. Fully aware of these factors, 
however, some parents expressed strong desire to proceed with 
helmet treatement for their child. We therefore became interested 
in determining whether this treatment modality was still eﬀective 
in these older children. 
Among the children studied, the mean CVA and CVAI had 
improved from 15.6 to 8 mm and from 9.42% to 4.91%, respective-
ly. Both of these before-after diﬀerences were statistically signiﬁ-
cant. These results indicated that head shape could be improved 
in infants older than 18 months, and also that helmet therapy was 
eﬀective in these older children. The average helmet therapy dura-
tion of 16.4 months was higher than those reported in other stud-
ies. Kluba et al. [15] reported the time to successful outcome in pa-
tients younger than 6 months and older than 6 months were 14 
weeks and 18 weeks of treatment, respectively. In their study, pa-
tients younger than 6 months had CVA improvement from 17 to 
4.5 mm, and CVAI was from 13.6% to 3.1%. Patients older than 6 
months had CVA improvement from 17 to 6.5 mm, and CVAI 
was from 13.1% to 4.5%.
Six of 27 patients were considered to have successful treatment 
outcome. All wore the helmet for more than 17 hours per day, and 
the mean helmet wearing time was 21.2 hours per day. Their CVA 
was improved, 10 mm (from 12.5 to 2.5 mm) and CVAI was 
5.05% (from 6.56% to 1.51%). The treatment duration for this sub-
group was 10.8 months.
Among patients who wore the helmet for less than 17 hours per 
a day, the CVA and CVAI was improved only 5 mm (from 16 to 11 
mm) and 2.96% (from 9.23% to 6.27 %), respectively. Their treat-
ment period was 20.6 months (Table 3). In a comparison between 
successful and unsuccessful outcome groups, there was no signiﬁ-
cant diﬀerence in the initial CVA, initial CVAI, and age at helmet 
treatment initiation. However, final CVA, final CVAI, compli-
ance, treatment period, and compliance were signiﬁcantly diﬀer-
ent. It means that good compliance could be a key of successful 
outcome, and can shortening helmet wearing duration. These re-
sults indicate that a more consistent sue of the helmet (maximal 
hours each day) can achieve a successful outcome, and can short-
en the overall duration of treatment. Twelve patients were consid-
ered to be in good compliance with a mean of 18.9 hours per day 
but did not reach successful outcome. Their CVA and CVAI were 
improved by a diﬀerence of 7 mm and 5.35%, respectively. These 
values represent relative improvements of approximately 50%. The 
helmet treatment was eﬀective in infants older than 18 months.
The limitation of our study was that we included completely 
treated patients. There was selection bias in this study because pa-
tients with better outcomes had no complications and more easily 
completed the treatment and came back for follow-up visits. Be-
cause of the small study size, we could not suggest an optimal du-
ration for helmet treatment for this older population of infants. If 
we are able to obtain a larger sample, we will conduct a future study 
to answer this question. Furthermore, long-term follow up is need-
ed to examine psychological aspects of using these devices for chil-
dren who are beginning the social phases of their development.   
This report reached a definitive conclusion that helmet treat-
ment was eﬀective in infants older than 18 months whose parents 
are able to comply with a strict helmet wearing regimen. Compli-
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ance was crucial to successful outcome; otherwise, longer treat-
ment durations were needed for older patients and was associated 
with additional burdens like cleansing, checking for correct fit-
ness, and skin irritation. However, if the helmet was used for more 
than 20 hours per a day, the duration of treatment was somewhat 
shortened. 
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